Conventional heart failure therapy in cardiac ATTR amyloidosis
European Heart Journal

Abstract
The aims of this study were to assess prescription patterns, dosages, discontinuation rates, and association with prognosis of conventional heart failure medications in patients with transthyretin cardiac amyloidosis (ATTR-CA).
A retrospective analysis of all consecutive patients diagnosed with ATTR-CA at the National Amyloidosis Centre between 2000 and 2022 identified 2371 patients with ATTR-CA. Prescription of heart failure medications was greater among patients with a more severe cardiac phenotype, comprising beta-blockers in 55.4%, angiotensin-converting enzyme inhibitors (ACEis)/angiotensin II receptor blockers (ARBs) in 57.4%, and mineralocorticoid receptor antagonists (MRAs) in 39.0% of cases. During a median follow-up of 27.8 months (interquartile range 10.6–51.3), 21.7% had beta-blockers discontinued, and 32.9% had ACEi/ARBs discontinued. In contrast, only 7.5% had MRAs discontinued. A propensity score-matched analysis demonstrated that treatment with MRAs was independently associated with a reduced risk of mortality in the overall population [hazard ratio (HR) 0.77 (95% confidence interval (CI) 0.66–0.89),
Conventional heart failure medications are currently not widely prescribed in ATTR-CA, and those that received medication had more severe cardiac disease. Beta-blockers and ACEi/ARBs were often discontinued, but low-dose beta-blockers were associated with reduced risk of mortality in patients with a LVEF ≤40%. In contrast, MRAs were rarely discontinued and were associated with reduced risk of mortality in the overall population; but these findings require confirmation in prospective randomized controlled trials.
Contributors

Helen Lachmann
Author

Ashutosh Wechelakar
Author

Mark Petrie
Author

Alun Hughes
Author

Nick Freemantle
Author

Philip N Hawkins
Author

Adam Ioannou
Author

Carol Whelan
Author

Paolo Massa
Author

Rishi K Patel
Author

Yousuf Razvi
Author

John J V McMurray
Author

Aldostefano Porcari
Author

Marianna Fontana
Author
University College London London , United Kingdom of Great Britain & Northern Ireland

Muhammad U Rauf
Author

Anita Jiang
Author

Giacomo Cabras
Author

Stefano Filisetti
Author

Roos E Bolhuis
Author

Francesco Bandera
Author

Lucia Venneri
Author

Ana Martinez-Naharro
Author

Steven Law
Author

Tushar Kotecha
Author

Ruta Virsinskaite
Author

Daniel S Knight
Author

Michele Emdin
Author

Aviva Petrie
Author
You may be interested in





